Just diagnosed with IgG4-related retroperitoneal fibrosis?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees IgG4-related retroperitoneal fibrosis, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive IgG4-related retroperitoneal fibrosis hub →Overview
IgG4-related retroperitoneal fibrosis is a rare condition. Also known as Idiopathic retroperitoneal fibrosis, Ormond disease. Tomeko brings together the specialists, research, clinical trials, treatments and community for IgG4-related retroperitoneal fibrosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:49041 · OMIM 228800 · ICD-10 K66.2 · GARD 0009568
Find care for IgG4-related retroperitoneal fibrosis
Authoritative references for IgG4-related retroperitoneal fibrosis
Research & market landscape for IgG4-related retroperitoneal fibrosis
Following IgG4-related retroperitoneal fibrosis for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for IgG4-related retroperitoneal fibrosis — the real-world landscape behind the condition, in one place.
- Latest IgG4-related retroperitoneal fibrosis research on PubMed ↗
- Recruiting IgG4-related retroperitoneal fibrosis trials on ClinicalTrials.gov ↗
- Explore the IgG4-related retroperitoneal fibrosis research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for IgG4-related retroperitoneal fibrosis and every rare condition. See how Tomeko works with industry →
Common questions
What is IgG4-related retroperitoneal fibrosis?
IgG4-related retroperitoneal fibrosis is a rare condition. Also known as Idiopathic retroperitoneal fibrosis, Ormond disease. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for IgG4-related retroperitoneal fibrosis together in one place.
What are the symptoms of IgG4-related retroperitoneal fibrosis?
Symptoms of IgG4-related retroperitoneal fibrosis vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats IgG4-related retroperitoneal fibrosis.
How is IgG4-related retroperitoneal fibrosis treated?
Treatment for IgG4-related retroperitoneal fibrosis depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see IgG4-related retroperitoneal fibrosis, and review current options with them.
What causes IgG4-related retroperitoneal fibrosis — is it genetic?
The cause and inheritance of IgG4-related retroperitoneal fibrosis are described in the authoritative references linked on this page. A genetics or specialist clinician who treats IgG4-related retroperitoneal fibrosis can explain what it means for you and your family.
I was just diagnosed with IgG4-related retroperitoneal fibrosis — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees IgG4-related retroperitoneal fibrosis, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for IgG4-related retroperitoneal fibrosis?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat IgG4-related retroperitoneal fibrosis, filtered to your area.
Are there clinical trials for IgG4-related retroperitoneal fibrosis?
Tomeko shows live, recruiting studies for IgG4-related retroperitoneal fibrosis from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: